BridgeBio Oncology Therapeutics, Inc. (BBOT) earnings · $610.4M cap
These earnings events as JSON? API free 100/dayBridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
This BBOT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BBOT revenue for 2026-06-30 was $3.6M. Net income was -$56.5M. Revenue was down 10.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
When the next BBOT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 10.0% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full BBOT research stays on the stock page; the tape stays on the quote page.
BBOT earnings FAQ
What are BBOT's latest revenue and net income?
Latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue for Jun 30, 2026 was $3.6M. Net income was -$56.5M. Statements: https://lician.com/financials/bbot
What is BBOT's latest diluted EPS?
Latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) diluted EPS for Jun 30, 2026 was -$0.71.
What period does the latest BBOT earnings print cover?
The latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did BBOT revenue change from the prior cached period?
Cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue was down 10.0% from $3.9M (Mar 31, 2026) to $3.6M (Jun 30, 2026). Statements: https://lician.com/financials/bbot
Where are BBOT earnings listed?
Cached earnings facts for BridgeBio Oncology Therapeutics, Inc. (BBOT) are listed at https://lician.com/earnings/bbot. Statements: https://lician.com/financials/bbot
Not investment advice.